Medications starting with
Spain-
It is used to treat and prevent bleeding in patients of any age with hemophilia A, a disorder caused by the deficiency or dysfunction of factor VIII.
Dosage form: powder and solvent for solution for injection
Active substance Dosage efmoroctocog alfa 750 UI Manufacturer: Swedish Orphan Biovitrum Ab (Publ)
-
It is used to relieve inflammation and itching caused by certain skin disorders, such as psoriasis (except for extensive plaques), atopic dermatitis, irritant dermatitis, and contact allergies.
Dosage form: cream
Active substance Dosage mometazone furoate 1 mg Manufacturer: Organon Salud S.L.
-
This medication is prescribed for the treatment of depression.
Dosage form: tablets, modified release
Active substance Dosage bupropion hydrochloride 150 mg Manufacturer: Glaxosmithkline S.A.
-
It is used for the treatment of depression.
Dosage form: tablets, modified release
Active substance Dosage bupropion hydrochloride 300 mg Manufacturer: Glaxosmithkline S.A.
-
Dosage form: solution for injection
Active substance Dosage corifolitropin alfa 100 µg Manufacturer: Organon N.V.
-
In women, it is used to help achieve pregnancy in infertility treatments, such as in vitro fertilization (IVF), by stimulating the growth of follicles in the ovaries. In adolescent males (from 14 years of age onwards), it is used to help the development of the testes and male sexual characteristics due to delayed puberty caused by hypogonadotropic hypogonadism (HH).
Dosage form: solution for injection
Active substance Dosage corifolitropin alfa 150 µg Manufacturer: Organon N.V.
-
It is used to treat circulatory disorders in the extremities caused by arteriosclerosis, diabetes, inflammation, or other causes, such as leg ulcers and gangrene.
Dosage form: tablets, prolonged-release
Active substance Dosage pentoxifylline 400 mg Manufacturer: Neuraxpharm Spain S.L.U.
-
It is used to treat adults with multiple myeloma, a type of bone marrow cancer, in patients whose cancer has recurred and no longer responds to previous treatments.
Dosage form: solution for injection
Active substance Dosage elranatamab 40 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune (primary) thrombocytopenia in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune (primary) thrombocytopenia in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,80 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune (primary) thrombocytopenia in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection who have had problems with interferon treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 95,70 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (primary) in patients 1 year of age or older who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 25 mg Manufacturer: Cipla Europe N.V.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients 1 year of age or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 50 mg Manufacturer: Cipla Europe N.V.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune (primary) thrombocytopenia in patients 1 year of age or older who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 75 mg Manufacturer: Cipla Europe N.V.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Reddy Pharma Iberia S.A.
-
It is used to help increase the number of platelets in the blood. It is used to treat immune (primary) thrombocytopenia in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,80 mg Manufacturer: Reddy Pharma Iberia S.A.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with interferon treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 95,70 mg Manufacturer: Reddy Pharma Iberia S.A.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients aged 1 year or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with interferon-based treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients aged 1 year or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with interferon-based therapy.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,80 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (primary) in patients 1 year of age or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Kern Pharma S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients 1 year of age or older who have not responded to other medicines, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with interferon treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,80 mg Manufacturer: Kern Pharma S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients 1 year of age or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with the adverse effects of interferon treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 95,70 mg Manufacturer: Kern Pharma S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,903 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with the adverse effects of interferon treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,806 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat (primary) immune thrombocytopenia in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,901 mg Manufacturer: Tarbis Farma S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,802 mg Manufacturer: Tarbis Farma S.L.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients 1 year of age or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with the adverse effects of interferon treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,900 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients 1 year of age or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,800 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients 1 year of age or older who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus (HCV) infection who have had problems with the adverse effects of interferon treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 95,700 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Viatris Limited
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection who have experienced problems with interferon side effects.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,80 mg Manufacturer: Viatris Limited
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,9 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection who have experienced problems with the adverse effects of interferon treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,8 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune thrombocytopenia (ITP) in patients over 1 year of age who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection who have experienced problems with the adverse effects of interferon treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 95,7 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune (primary) thrombocytopenia in patients 1 year of age or older who have not responded to other treatments, and also to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 31,90 mg Manufacturer: Zentiva K.S.
-
It is used to help increase the number of platelets in the blood. It is prescribed to treat immune (primary) thrombocytopenia in patients 1 year of age or older who have not responded to other medications, and to treat low platelet levels in adults with hepatitis C virus infection.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag olamine 63,8 mg Manufacturer: Zentiva K.S.
-
It is a contrast medium used to improve image visualization during magnetic resonance imaging (MRI) scans, helping to distinguish between healthy and diseased tissue.
Dosage form: solution for injection
Active substance Dosage gadopiclenol 485,1 mg Manufacturer: Guerbet
-
It is used as a contrast medium to improve the visualization of structures or lesions during magnetic resonance imaging (MRI) scans, helping to differentiate healthy tissue from diseased tissue.
Dosage form: solution for injection
Active substance Dosage gadopiclenol 485,1 mg Manufacturer: Guerbet
-
It is used as part of a comprehensive treatment for attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years (when other treatments have not been effective) and in adults who have had ADHD since childhood. It helps improve attention, concentration, and reduces impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 30.0 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is used as part of a comprehensive treatment for attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years (when other treatments have not been effective) and in adults who have had ADHD since childhood. It helps improve attention, concentration, and reduces impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 50,0 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is used as part of a comprehensive treatment program for attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years (when other treatments have not worked) and in adults who have had ADHD since childhood. It helps improve attention and concentration and reduce impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 70.0 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is used as part of a comprehensive treatment program for attention deficit hyperactivity disorder (ADHD) in adults who have had this condition since childhood. It helps improve attention and concentration and reduce impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 30 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is used as part of a comprehensive treatment program for attention deficit hyperactivity disorder (ADHD) in adults who have had this condition since childhood. It helps improve attention and concentration and reduce impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 50 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is used as part of a comprehensive treatment for attention deficit hyperactivity disorder (ADHD) in adults who have had this condition since childhood. It helps improve attention and concentration and reduce impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 70 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is used to treat seasonal allergic conjunctivitis of the eyes, helping to reduce the severity of the allergic reaction caused by substances such as pollen, dust, or animal hair.
Dosage form: solution, ophthalmic
Active substance Dosage emedastine fumarate 0,5 mg Manufacturer: Immedica Pharma Ab
-
It is used for the short-term treatment of reflux symptoms, such as heartburn (a painful sensation in the chest that rises to the throat) and acid regurgitation (a sour taste in the mouth).
Dosage form: capsules, hard, enteric-coated
Active substance Dosage esomeprazole magnesium 20,645 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used to treat gastroesophageal reflux disease (GERD), excessive acidity caused by a tumor in the pancreas (Zollinger-Ellison syndrome), and as maintenance treatment after preventing ulcer rebleeding.
Dosage form: capsules, gastro-resistant
Active substance Dosage esomeprazole magnesium 41,29 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used in adults to treat complicated abdominal infections, hospital-acquired pneumonia (including ventilator-associated pneumonia), complicated urinary tract infections (such as pyelonephritis), and infections caused by Gram-negative bacteria that other antibiotics cannot eliminate.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage avibactam sodium 542 mg aztreonam 1500 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to treat high blood pressure (hypertension) and stable chronic angina pectoris.
Dosage form: tablets, film-coated
Active substance Dosage bisoprolol hemifumarate 10 mg Manufacturer: Merck S.L.
-
It is used to treat high blood pressure (hypertension) and stable chronic angina pectoris.
Dosage form: tablets, film-coated
Active substance Dosage bisoprolol hemifumarate 5 mg Manufacturer: Merck S.L.